Pfizer's Options: A Look at What the Big Money is Thinking
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have shown a significant interest in Pfizer (NYSE:PFE) options, with a nearly even split between bullish and bearish sentiments. Benzinga's options scanner revealed 9 extraordinary activities, indicating a targeted price range for PFE between $17.5 to $35.0. The largest trades include both calls and puts, with varying sentiments and strike prices. Pfizer, a leading pharmaceutical company, is currently trading at $25.41, up 0.57%, with an RSI suggesting it may be oversold. Analysts have a consensus target price of $45.0 for PFE, despite a recent downgrade by Cantor Fitzgerald to Overweight.
April 26, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer has seen significant options trading activity, indicating investor interest and potential volatility. The stock is currently up, with analysts maintaining a positive outlook despite a recent downgrade.
The significant options activity, coupled with the stock's current performance and analyst ratings, suggests a positive short-term outlook. However, the mixed sentiments in options trading and the recent downgrade by Cantor Fitzgerald introduce a level of uncertainty, which is mitigated by the overall bullish consensus among analysts.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100